Sonova launched its third hearing-aid platform utilising real-time AI on Monday, its latest effort to strengthen its position in a market that relies on rapid technology upgrades to shorten replacement cycles and attract first-time users.
Sonova Holding AG (SONVY) Q4 2026 Earnings Call Transcript
Sonova Holding AG (SONVY) Discusses Refreshed Strategy and Vision for Next Phase of Growth Transcript
| Health Care Equipment & Supplies Industry | Healthcare Sector | Eric Alain Bernard CEO | XFRA Exchange | 83569C102 CUSIP |
| CH Country | 18,447 Employees | 22 Jun 2026 Last Dividend | 17 Jun 2020 Last Split | - IPO Date |
Sonova Holding AG is a pioneering company in the design, development, manufacturing, and distribution of hearing care solutions for both adults and children. The company operates under two primary segments: Hearing Instruments and Cochlear Implants. Initially named Phonak Holding AG, the company underwent a name change in August 2007 and adopted its current name, Sonova Holding AG. Since its inception in 1947, Sonova has established itself as a key player in the hearing care industry and is known for its innovative solutions and comprehensive care services. Headquartered in Stäfa, Switzerland, Sonova has a global presence, with operations spanning the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company's distribution network includes independent distributors and a vast chain of approximately 3,600 stores and clinics, ensuring accessibility to its products and services worldwide.
Sonova Holding AG's product lineup and service offerings are extensive, covering a wide range of hearing and sound enhancement devices, as well as audiological care services. These include: